Practice Guidelines

ACIP Releases 2016 Adult Immunization Recommendations

 


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2016 Feb 15;93(4):323-326.

Key Points for Practice

• Nonavalent HPV vaccine can be used for routine vaccination in adolescents and adults.

• Human immunodeficiency virus infection is not an indication for routine vaccination with MenACWY-D or meningococcal B vaccine.

• The interval of at least one year between administering PCV13 and PPSV23 in adults 65 years and older aligns with the ACIP recommendation and Centers for Medicare and Medicaid Services coverage policy.

From the AFP Editors

Each year, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention reviews and updates the adult immunization schedule to incorporate any published updates or corrections from the previous year. The 2016 adult immunization schedule is available at http://www.aafp.org/patient-care/immunizations/schedules.html.

Human Papillomavirus Vaccine

In February 2015, the ACIP recommended nonavalent human papillomavirus (HPV) vaccine (Gardasil 9) as one of three formulations that can be used for routine vaccination in adolescents and adults. The nonavalent HPV vaccine is a noninfectious, virus-like

editor's note: The author serves as liaison to ACIP for the AAFP.

Address correspondence to Margot Savoy, MD, MPH, at msavoy@christianacare.org. Reprints are not available from the author.

Author disclosure: No relevant financial affiliations.

REFERENCES

1. Petrosky E, Bocchini JA Jr, Hariri S, et al.; Centers for Disease Control and Prevention. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–304. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm. Accessed October 22, 2015.

2. Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR; Centers for Disease Control and Prevention. Use of serogroup B meningococcal vaccines in persons aged ≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015 [published correction appears in MMWR Morb Mortal Wkly Rep. 2015;64(29):806]. MMWR Morb Mortal Wkly Rep. 2015;64(22):608–612. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6422a3.htm. Accessed October 22, 2015.

3. Kobayashi M, Bennett NM, Gierke R, et al. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015;64(34):944–947. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6434a4.htm. Accessed October 22, 2015.

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.

A collection of Practice Guidelines published in AFP is available at http://www.aafp.org/afp/practguide.



 

Copyright © 2016 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP

More in Pubmed

MOST RECENT ISSUE


Sep 15, 2016

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article